Home/Filings/4/0001415889-23-015095
4//SEC Filing

Dais Craig 4

Accession 0001415889-23-015095

CIK 0000810509other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:38 PM ET

Size

4.9 KB

Accession

0001415889-23-015095

Insider Transaction Report

Form 4
Period: 2023-11-10
Dais Craig
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-11-10+973,633973,633 total
Footnotes (1)
  • [F1]Shares of stock vest in two tranches: 50% vest upon the date of the grant and the remaining 50% shall vest upon the one-year anniversary of the grant date, subject to Mr. Dais' continued employment with the Company.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001990095

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:38 PM ET
Size
4.9 KB